Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Vivek C. Abraham et al.|Cancer Research|2021Cited by 52
Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Fritz G. Buchanan et al.|Unknown|2023Cited by 0
Supplementary Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Fritz G. Buchanan et al.|Unknown|2023Cited by 0
Supplementary Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Fritz G. Buchanan et al.|Unknown|2023Cited by 0
Data from Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Fritz G. Buchanan et al.|Unknown|2023Cited by 0